Hernando, C., Ortega-Morillo, B., Tapia, M., Moragon, S., Martinez, M., Eroles, P., . . . Cejalvo, J. (2021). Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective.
Citación estilo ChicagoHernando, C., et al. Oral Selective Estrogen Receptor Degraders (SERDs) As a Novel Breast Cancer Therapy: Present and Future From a Clinical Perspective. 2021.
Cita MLAHernando, C., et al. Oral Selective Estrogen Receptor Degraders (SERDs) As a Novel Breast Cancer Therapy: Present and Future From a Clinical Perspective. 2021.
Precaución: Estas citas no son 100% exactas.